COGZFCogstate Limited
The schedule
- Thu15Oct
Scheduled Annual General Meeting providing Q1 trading performance and backlog conversion visibility.
- Fri20Nov
Market pricing of potential delays in clinical trial starts given prior management caution on the pace of contract conversion.
- Thu18Feb
Release of first-half FY27 financial results, revealing whether the 116% YoY surge in new FY26 sales contracts has converted into top-line revenue.
- Tue18May
Anticipated operational update on Cogstate's strategic alliance with Eisai and adoption of digital cognitive assessments alongside new Alzheimer's therapeutics.
- Tue17Aug
Full year FY27 earnings release, providing the ultimate verdict on the execution of the company's multi-year capacity expansion.
Past
- Tue18Aug
Actual outcome: Bull
COGZF experienced a significant short-term price surge due to an earnings report that exceeded expectations, accompanied by upbeat forward guidance. The results showcased stronger-than-anticipated revenue and margin expansion, signaling improved operational performance and strategic execution. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-09-14: +50.0% from 2026-08-06 (~3.9σ). Target date 2026-08-25 reached; move through 2026-09-14 observed.
COGZF experienced a significant short-term price surge due to an earnings report that exceeded expectations, accompanied by upbeat forward guidance. The results showcased stronger-than-anticipated revenue and margin expansion, signaling improved operational performance and strategic execution. [Market retrospective · Short-Term (6–10 days)] Updated observation 2026-09-14: +50.0% from 2026-08-06 (~3.9σ). Target date 2026-08-25 reached; move through 2026-09-14 observed.